Affiliation:
1. Department of Neurology David Geffen School of Medicine at UCLA Los Angeles CA USA
2. Imaging Genetics Center, Institute for Neuroimaging and Informatics Department of Neurology, Keck/USC School of Medicine University of Southern California Los Angeles CA USA
3. Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine at UCLA Los Angeles CA USA
4. Departments of Psychiatry, Engineering, Radiology, & Ophthalmology, Keck/USC School of Medicine University of Southern California Los Angeles CA USA
Funder
A.P. Giannini Foundation
National Institutes of Health
Alzheimer's Disease Neuroimaging Initiative
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
National Institutes of Health Grant
the National Institute of Biomedical Imaging and Bioengineering
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
BioClinica, Inc.
Biogen Idec Inc.
Bristol-Myers Squibb Company
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Genentech, Inc.
GE Healthcare
Innogenetics, N.V.
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Medpace, Inc.
Merck & Co., Inc.
Meso Scale Diagnostics, LLC.
NeuroRx Research
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging; Servier
Synarc Inc.
Takeda Pharmaceutical Company
Canadian Institutes of Health Research
Northern California Institute for Research and Education
NIH
Subject
Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology
Reference69 articles.
1. Dopamine and the regulation of cognition and attention
2. SchuckNW FrenschPA SchjeideBM SchroderJ BertramL et al.Effects of aging and dopamine genotypes on the emergence of explicit memory during sequence learning.Neuropsychologia2013
3. Association analysis of dopaminergic gene variants (Comt, Drd4 And Dat1) with Alzheimer s disease;Lin WY;J Biol Regul Homeost Agents,2012
4. Genomic Features of the Human Dopamine Transporter Gene and Its Potential Epigenetic States: Implications for Phenotypic Diversity
5. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR